The North American Neuromodulation Society (NANS) has opened the public comment period for its draft Clinical Guideline on Implantable Peripheral Nerve Stimulation (PNS) for Chronic Pain—one of the first formal guideline initiatives undertaken by the Society.
Developed by a multidisciplinary panel, the guideline provides a rigorous, evidence-based appraisal of the current literature on implantable PNS across chronic pain indications, including anatomical and indication-specific recommendations supported by graded levels of evidence.
As the clinical use of PNS continues to expand, the guideline aims to clarify where strong evidence exists, where emerging evidence may support clinical use, and where important research gaps remain.
As part of the guideline development process, NANS has opened a public comment period to allow stakeholders to review the draft recommendations. Submitted comments will be considered by the guideline development panel; however, feedback is advisory in nature, and NANS is not obligated to make revisions based on submitted comments.
The public comment period is now closed.